Business
GB Sciences Revered Founder, Craig Ellins, Retires
GB Sciences Revered Founder, Craig Ellins, Retires.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Revered Founder, Craig Ellins, Retires\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Revered Founder, Craig Ellins, Retires\nPR Newswire\nLAS VEGAS, May 8, 2017\n\n\n\nLAS VEGAS, May 8, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces the retirement and resignation, effective May 8, 2017, of its founder, Chairman and Chief Innovation Officer, Craig Ellins.\n\nMr. Ellins is the brilliant visionary behind the company's focus on pharmaceutical grade, consistent and efficacious medicines as well as much of its proprietary technology designed to produce and enhance those medicines.  Principal among these is the groundbreaking GB tissue propagation technique that allows for identical plants to be cultivated, as opposed to the traditional methods of generational growing – where one plant is descended from its progenitor.\n\nJohn Poss, who replaced Mr. Ellins as CEO last year, now also serves as Chairman of the Board.\n\nMr. Poss said: \"We are all very disappointed to see Craig retire.  His brilliance and guidance have steered this company to this major inflection point---where we are now positioned to become the Biopharma company of the future.  The entire GB Sciences family will miss him and we wish him all the best.\"\n\nMr. Ellins states: \"Of course it's difficult to leave this wonderful place, but I am very gratified that John Poss and the excellent team he has assembled have done such a wonderful job; thanks to them, I retire knowing that the seed I planted will blossom in the hands of some very talented managers and scientists.\"\n\nAbout GB Sciences, Inc.\n\nGB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://growblox.com.\n\nForward-Looking Statements\n\nThis press release may contain stat...